Literature DB >> 19360877

Carotid artery stenting: do procedural complications relate to the side intervened upon?: results from the Carotid Artery Stent (CAS)-Registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).

Ralf Zahn1, Thomas Ischinger, Matthias Hochadel, Bernd Mark, Uwe Zeymer, Wolfgang Schmalz, Alexander Schramm, Karl Eugen Hauptmann, Hubert Seggewiss, Ilse Janicke, Harald Mudra, Jochen Senges.   

Abstract

OBJECTIVES: To determine the influence of the side intervened upon on outcomes during carotid artery stenting (CAS).
BACKGROUND: Anatomic and technical aspects may influence the results of CAS. The value of the side intervened upon has not been analyzed yet.
METHODS: We analyzed data from the Carotid Artery Stent (CAS)-Registry.
RESULTS: A total of 3,165 CAS procedures, 1,613 (51%) at the left and 1,552 (49%) at the right carotid artery were included. There was a higher proportion of patients treated for symptomatic stenoses when CAS was performed at the left carotid artery (50.1% versus 45.8%, P = 0.016) and more patients already had prior carotid endarterectomy (8.5% versus 5.8%, P = 0.003). Interventions at the left side took 3 min longer than interventions at the right side (46.6 +/- 24.3 versus 43.8 +/- 23.6, P = 0.003). In patients treated at the left carotid artery amaurosis fugax (0.7% versus 0.1%, P = 0.005), ipsilateral stroke (3.1% versus 1.8%, P = 0.017), and the primary endpoint of in-hospital death or stroke (4.1% versus 2.3%, P = 0.005) occurred significantly more often. Even after adjusting for confounding parameters, CAS procedures performed at the left carotid arteries remained an independent predictor of death or stroke (OR = 1.77, 95% CI: 1.15-2.72, P = 0.009).
CONCLUSIONS: In current clinical practice, CAS is performed frequently at the right carotid artery as at the left carotid artery. CAS interventions have a higher in-hospital complication rate if performed at the left carotid artery. Technical improvements might help to overcome this situation. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19360877     DOI: 10.1002/ccd.22050

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  5 in total

Review 1.  Anticoagulation in neurointerventions: basic pharmacology and pathophysiology, current status, practical advice.

Authors:  J Scharf; C-E Dempfle
Journal:  Clin Neuroradiol       Date:  2012-02-07       Impact factor: 3.649

2.  The role of endovascular expertise in carotid artery stenting: results from the ALKK-CAS-Registry in 5,535 patients.

Authors:  Stephan Staubach; Ralph Hein-Rothweiler; Matthias Hochadel; Manuela Segerer; Ralf Zahn; Jens Jung; Gotthard Riess; Hubert Seggewiss; Andre Schneider; Thomas Fürste; Christian Gottkehaskamp; Harald Mudra
Journal:  Clin Res Cardiol       Date:  2012-05-30       Impact factor: 5.460

3.  [GeCAS registry. Sense and purpose of a carotid percutaneous transluminal angioplasty register in the era of obligatory quality assurance].

Authors:  N Werner; R Zahn
Journal:  Herz       Date:  2013-11       Impact factor: 1.443

4.  Predictors of minor versus major stroke during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).

Authors:  Stephan Staubach; Ralph Hein-Rothweiler; Matthias Hochadel; Manuela Segerer; Ralf Zahn; Jens Jung; Gotthard Riess; Hubert Seggewiss; Andre Schneider; Thomas Fürste; Christian Gottkehaskamp; Harald Mudra
Journal:  Clin Res Cardiol       Date:  2014-01-11       Impact factor: 5.460

5.  Peri-interventional neurological complication rates in patients undergoing carotid artery stenting depend on the side of the stenosis treated.

Authors:  Kammler Juergen; Blessberger Hermann; Lichtenauer Michael; Lambert Thomas; Kellermair Joerg; Nahler Alexander; Schwarz Stefan; Reiter Christian; Grund Michael; Kypta Alexander; Steinwender Clemens
Journal:  Heart Vessels       Date:  2017-05-04       Impact factor: 2.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.